These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35343344)

  • 1. Toward genetic counseling practice standards for diagnostic testing in amyotrophic lateral sclerosis and frontotemporal dementia.
    Crook A; Jacobs C; Newton-John T; McEwen A
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Nov; 23(7-8):562-574. PubMed ID: 35343344
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic counseling and diagnostic genetic testing for familial amyotrophic lateral sclerosis and/or frontotemporal dementia: A qualitative study of client experiences.
    Crook A; Jacobs C; Newton-John T; McEwen A
    J Genet Couns; 2022 Oct; 31(5):1206-1218. PubMed ID: 35635300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations.
    Crook A; Williams K; Adams L; Blair I; Rowe DB
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):475-485. PubMed ID: 28585888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and Relative Experiences and Decision-making About Genetic Testing and Counseling for Familial ALS and FTD: A Systematic Scoping Review.
    Crook A; Jacobs C; Newton-John T; Richardson E; McEwen A
    Alzheimer Dis Assoc Disord; 2021 Oct-Dec 01; 35(4):374-385. PubMed ID: 34054018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Impact on Clinical Management.
    Roggenbuck J; Fong JC
    Clin Lab Med; 2020 Sep; 40(3):271-287. PubMed ID: 32718499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Overlapping features of frontotemporal dementia and amyotrophic lateral sclerosis].
    Lillo P; Matamala JM; Valenzuela D; Verdugo R; Castillo JL; Ibáñez A; Slachevsky A
    Rev Med Chil; 2014 Jul; 142(7):867-79. PubMed ID: 25378006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians.
    Roggenbuck J; Quick A; Kolb SJ
    Genet Med; 2017 Mar; 19(3):267-274. PubMed ID: 27537704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Counseling Dilemmas for a Patient with Sporadic Amyotrophic Lateral Sclerosis, Frontotemporal Degeneration & Parkinson's Disease.
    Mantero V; Tarlarini C; Aliprandi A; Lauria G; Rigamonti A; Abate L; Origone P; Mandich P; Penco S; Salmaggi A
    J Genet Couns; 2017 Jun; 26(3):442-446. PubMed ID: 28247171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The
    Crook A; McEwen A; Fifita JA; Zhang K; Kwok JB; Halliday G; Blair IP; Rowe DB
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):310-316. PubMed ID: 30907153
    [No Abstract]   [Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.
    Strong MJ; Abrahams S; Goldstein LH; Woolley S; Mclaughlin P; Snowden J; Mioshi E; Roberts-South A; Benatar M; HortobáGyi T; Rosenfeld J; Silani V; Ince PG; Turner MR
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):153-174. PubMed ID: 28054827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72.
    Snowden JS; Harris J; Richardson A; Rollinson S; Thompson JC; Neary D; Mann DM; Pickering-Brown S
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):172-6. PubMed ID: 23421625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic counselling in ALS: facts, uncertainties and clinical suggestions.
    Chiò A; Battistini S; Calvo A; Caponnetto C; Conforti FL; Corbo M; Giannini F; Mandrioli J; Mora G; Sabatelli M; ; Ajmone C; Mastro E; Pain D; Mandich P; Penco S; Restagno G; Zollino M; Surbone A
    J Neurol Neurosurg Psychiatry; 2014 May; 85(5):478-85. PubMed ID: 23833266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis.
    Saxon JA; Thompson JC; Harris JM; Richardson AM; Langheinrich T; Rollinson S; Pickering-Brown S; Chaouch A; Ealing J; Hamdalla H; Young CA; Blackburn D; Majeed T; Gall C; Jones M; Snowden JS
    J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1304-1311. PubMed ID: 33055142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALS and frontotemporal dementia belong to a common disease spectrum.
    Couratier P; Corcia P; Lautrette G; Nicol M; Marin B
    Rev Neurol (Paris); 2017 May; 173(5):273-279. PubMed ID: 28449882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amyotrophic lateral sclerosis and frontotemporal dementia: overlapping characteristics].
    Raaphorst J; Grupstra HF; Linssen WH; van Swieten JC; Schmand B; de Visser M
    Ned Tijdschr Geneeskd; 2010; 154():A631. PubMed ID: 20178658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the Genetic Profile of the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia (ALS-FTD) Continuum in Patients of Diverse Race, Ethnicity and Ancestry.
    Mesaros M; Lenz S; Lim W; Brown J; Drury L; Roggenbuck J
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyotrophic lateral sclerosis; clinical features, differential diagnosis and pathology.
    Van Es MA
    Int Rev Neurobiol; 2024; 176():1-47. PubMed ID: 38802173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers.
    Akiyama T; Koike Y; Petrucelli L; Gitler AD
    Clin Transl Med; 2022 May; 12(5):e818. PubMed ID: 35567447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia.
    Farhan SMK; Gendron TF; Petrucelli L; Hegele RA; Strong MJ
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):75-85. PubMed ID: 29080331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.